Company seeks to raise funds through a new rights offering.
- Bioretec Ltd aims to issue new shares to raise funds.
- Planned rights issue could reach up to EUR 15 million.
- Financing will support future growth initiatives.
Bioretec Ltd is planning a rights issue aimed at raising a minimum of EUR 5 million, with the potential to increase to EUR 15 million. The company intends to issue a maximum of 1.5 billion new shares as part of this initiative. This fundraising effort is designed to support the company’s ongoing projects and future growth opportunities in the biotechnology sector.
The rights offering comes as Bioretec seeks to secure the financial resources needed to advance its product development and market strategies. This move is expected to enhance the company’s capital structure and investment potential. Shareholders will have the opportunity to participate in the rights issue, allowing them to support the company’s financial objectives directly.
